Dengue In Latin America And The Caribbean Countries- The Cases Increased And Changes In The Circulation Of The Virus

Published Mar 10, 2014
Buenos Aires, Argentina - Even though during the 1960s and the early 1970s dengue transmission was interrupted in the Americas due to policies implemented to prevent yellow fever, in the last decade the disease has become a serious problem globally and for Latin America and the Caribbean countries. Spread by mosquitoes (Aedesaegypti) nowadays, dengue affects 50 to 100 million people annually, with high morbidity and associated mortality. Young adults are the most affected and in some countries there´s also an increment in cases within pediatric population. In this study, published in Value in Health Regional Issues entitled, Dengue Epidemiology and Burden of Disease in Latin America and the Caribbean: A Systematic Review of the Literature and Meta-Analysis,” we performed a comprehensive review of scientific literature and official country´s information, to portrait the epidemiology of dengue in the region. We found an increase in the incidence of dengue between 1995 and 2010 in Latin America and the Caribbean countries. The pattern of intermittent epidemics with long free intervals registered some decades ago changed to annual outbreaks, and a persistent co-circulation of several dengue virus types was noticed. More than 60% of cases came from Brazil. As dengue represents a substantial economic burden in the overall economy of the region we consider that this study will be useful to inform authorities in order to plan public health interventions.

Value in Health Regional Issues (ISSN 2212-1099) is a scientific journal that encourages and enhances the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions. The journal is published up to three times a year with one issue focusing on the Asia region, one issue focusing on the Latin America region, and one issue focusing on the Central & Eastern Europe, Western Asia and Africa regions.

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

Related Stories

Value in Health Regional Issues Expands Editorial Scope and Reveals Plans to Transition to Gold Open Access Model

Jan 23, 2024

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Empowering Change: Transforming Health Systems in Low- and Middle-Income Countries

Jan 22, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.

ISPOR’s Value in Health Regional Issues Receives Its First Impact Factor Score

Aug 7, 2023

Value in Health Regional Issues, the regionally focused journal of ISPOR, received its first-ever impact factor score this year. Value in Health, one of the top-ranked journals in the HEOR field, maintained its high ranking on the prestigious list of scholarly journals.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×